UBS Group AG - CONMED CORP ownership

CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 35 filers reported holding CONMED CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CONMED CORP
ValueSharesWeighting
Q2 2022$1,000
-90.0%
1,000
-88.9%
0.00%
Q3 2020$10,000
+42.9%
9,000
+28.6%
0.00%
Q2 2020$7,0007,0000.00%
Other shareholders
CONMED CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 2,840,000$3,958,0004.02%
ZAZOVE ASSOCIATES LLC 13,564,000$18,956,0002.33%
SHENKMAN CAPITAL MANAGEMENT INC 10,584,000$15,014,0001.57%
SSI INVESTMENT MANAGEMENT LLC 8,349,000$11,673,0000.83%
OSTERWEIS CAPITAL MANAGEMENT INC 8,930,000$12,528,0000.75%
MACKAY SHIELDS LLC 32,384,000$45,397,0000.31%
ADVENT CAPITAL MANAGEMENT /DE/ 8,379,000$11,734,0000.25%
PALISADE CAPITAL MANAGEMENT, LP 5,271,000$7,387,0000.19%
Calamos Advisors LLC 23,007,000$32,262,0000.19%
WESTWOOD HOLDINGS GROUP INC 10,200,000$14,415,0000.17%
View complete list of CONMED CORP shareholders